JMP Securities Upgrades Salix Pharmaceuticals (SLXP) to Market Outperform
Tweet
Share
E-mailGet Alerts SLXP Hot Sheet
Price: $172.81 --0%
Rating Summary:
7 Buy, 14 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Rating Summary:
7 Buy, 14 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Join SI Premium – FREE
JMP Securities upgraded Salix Pharmaceuticals (NASDAQ: SLXP) from Market Perform to Market Outperform. PT $48.
For more ratings news on Salix Pharmaceuticals click here and for the rating history of Salix Pharmaceuticals click here.
Shares of Salix Pharmaceuticals closed at $38.84 yesterday.
For more ratings news on Salix Pharmaceuticals click here and for the rating history of Salix Pharmaceuticals click here.
Shares of Salix Pharmaceuticals closed at $38.84 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Northland Upgrades Hyliion Holdings (HYLN) to Outperform 'on Improved Visibility to KARNO Commercialization'
- Wolfe Research Upgrades Biogen (BIIB) to Outperform
- Wolfe Research Upgrades Abbvie (ABBV) to Outperform
Create E-mail Alert Related Categories
UpgradesRelated Entities
JMP SecuritiesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
